Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Expédition mondial!
Plus d'info »
Myosin, a structural component of muscle, consists of two heavy chains and four light chains. De plus, nous expédions Myosin Regulatory Light Chain 2, Smooth Muscle Isoform Kits (22) et Myosin Regulatory Light Chain 2, Smooth Muscle Isoform Protéines (12) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 107 products:
Dog (Canine) Polyclonal MYL9 Primary Antibody pour IF (p), IHC (p) - ABIN872283 : Ikemura, Yamamoto, Motomura, Yamaguchi, Zhao, Iwasaki, Iwamoto: Preventive effects of the anti-vasospasm agent via the regulation of the Rho-kinase pathway on the development of steroid-induced osteonecrosis in rabbits. dans Bone 2013 (PubMed) Show all 3 Pubmed References
MYL9 expression might be a promising prognostic marker and therapeutic target in ESCC
At the cleavage furrow Arv1 (Montrer ARV1 Anticorps) recruits myosin heavy chain 9 (MYH9 (Montrer MYH9 Anticorps)) and myosin light chain 9 (MYL9) by interacting with IQ-motif-containing GTPase-activating protein (Montrer RASA1 Anticorps) (IQGAP1 (Montrer IQGAP1 Anticorps)).
These findings suggested that low MYLK (Montrer MYLK Anticorps) and MYL9 expressions might be associated with the development of NSCLC.
the decreased expression of MYL9 may play an important role in tumor progression of prostate cancer
Overexpression of MRTF-A (Montrer MKL1 Anticorps) significantly promoted the migration of MCF-7 cells through its transactivation effects on MYL9 and CYR61 (Montrer CYR61 Anticorps) genes
Overexpression of SMYD3 (Montrer SMYD3 Anticorps) promotes MRTF-A (Montrer MKL1 Anticorps)-mediated upregulation of MYL9 and migration of MCF-7 breast cancer cells
surface CD3 (Montrer CD3 Anticorps) expression proceeds through both MYL9-dependent and MYL9-independent pathways (i.e. the protein kinase C (Montrer PKC Anticorps)- dependent pathway) in Jurkat cells.
Endogenous Nogo-B (Montrer RTN4 Anticorps), which may exert its effects through ARPC 2 (Montrer ARPC2 Anticorps)/3 and MYL-9, is necessary for the migration and contraction of airway smooth muscle cells.
The FHC (Montrer FTH1 Anticorps)-mediated structural perturbations in RLC that affect Ca(2 (Montrer CA2 Anticorps)+) binding properties of mutated myocardium are responsible for triggering the abnormal function of the heart that in turn might initiate a hypertrophic process and lead to heart failure.
Smooth muscle type isoform, MLC-2C, is the inducible isoform, and might play a crucial role in monocyte/macrophage cell lineage.
Myosin, a structural component of muscle, consists of two heavy chains and four light chains. The protein encoded by this gene is a myosin light chain that may regulate muscle contraction by modulating the ATPase activity of myosin heads. The encoded protein binds calcium and is activated by myosin light chain kinase. Two transcript variants encoding different isoforms have been found for this gene.
20 kDa myosin light chain , myosin RLC , myosin regulatory light chain 1 , myosin regulatory light chain 2, smooth muscle isoform , myosin regulatory light chain 9 , myosin regulatory light chain MRLC1 , myosin regulatory light polypeptide 9 , myosin, light polypeptide 9, regulatory , myosin light chain, regulatory C , DTNB , G1 , MLC-2 , isoform L20-A , light polypeptide 9 , myosin light chain 2 , myosin regulatory light chain 2, smooth muscle major isoform , smooth muscle major isoform , myl9 , myosin, light chain 9, regulatory , uncharacterized protein LOC450006